Literature DB >> 18226798

Changes in the quality-of-life of people with keratoconus.

Steven M Kymes1, Jeffrey J Walline, Karla Zadnik, John Sterling, Mae O Gordon.   

Abstract

PURPOSE: The Collaborative Longitudinal Evaluation of Keratoconus Study (CLEK) previously showed that people with keratoconus report significantly impaired vision-related quality-of-life (V-QoL), as measured on the National Eye Institute Visual Function Questionnaire (NEI-VFQ), similar to that of people who have severe macular degeneration. For this study, we evaluated changes that occurred in V-QoL over seven years of follow-up.
DESIGN: In this prospective cohort study of 1,166 participants followed up for seven years, we estimated change in V-QoL by projecting the slope of a minimum of three reports on 11 scales of the NEI-VFQ. Correlation with clinical indicators was evaluated, and differences were assessed between those who had clinically significant changes in clinical factors and those who did not. Logistic regression was used to assess factors associated with a decline in 10 points or more in a scale score over seven years.
RESULTS: All scales showed modest decline except ocular pain and mental health. Baseline factors were not associated with longitudinal change in NEI-VFQ scores. A 10-letter decline in high-contrast binocular visual acuity or a 3.00-diopter increase in corneal curvature were associated with significantly larger declines in V-QoL. In multivariate analysis, these factors also were found to be associated with a 10-point decline in NEI-VFQ scale scores.
CONCLUSIONS: Keratoconus is associated with significantly impaired V-QoL that continues to decline over time. For a substantial plurality of patients, these declines are significant.

Entities:  

Mesh:

Year:  2008        PMID: 18226798      PMCID: PMC2753249          DOI: 10.1016/j.ajo.2007.11.017

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.

Authors: 
Journal:  Control Clin Trials       Date:  1999-12

Review 2.  Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Authors:  Geoffrey R Norman; Jeff A Sloan; Kathleen W Wyrwich
Journal:  Med Care       Date:  2003-05       Impact factor: 2.983

3.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

4.  Quality of life in keratoconus.

Authors:  Steven M Kymes; Jeffrey J Walline; Karla Zadnik; Mae O Gordon
Journal:  Am J Ophthalmol       Date:  2004-10       Impact factor: 5.258

5.  Clinical management of keratoconus. A multicenter analysis.

Authors:  J H Lass; R G Lembach; S B Park; D L Hom; M E Fritz; G M Svilar; I F Nuamah; W J Reinhart; E G Stocker; R H Keates
Journal:  Ophthalmology       Date:  1990-04       Impact factor: 12.079

6.  Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons.

Authors:  C M Mangione; S Berry; K Spritzer; N K Janz; R Klein; C Owsley; P P Lee
Journal:  Arch Ophthalmol       Date:  1998-02

7.  Keratoconus, magnesium deficiency, type A behavior, and allergy.

Authors:  A Thalasselis; H F Taie; J Etchepareborda; A Selim
Journal:  Am J Optom Physiol Opt       Date:  1988-06

8.  A 48-year clinical and epidemiologic study of keratoconus.

Authors:  R H Kennedy; W M Bourne; J A Dyer
Journal:  Am J Ophthalmol       Date:  1986-03-15       Impact factor: 5.258

9.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Authors:  Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2002-06

10.  Baseline factors predictive of incident penetrating keratoplasty in keratoconus.

Authors:  Mae O Gordon; Karen Steger-May; Loretta Szczotka-Flynn; Colleen Riley; Charlotte E Joslin; Barry A Weissman; Barbara A Fink; Timothy B Edrington; Harald E Olafsson; Karla Zadnik
Journal:  Am J Ophthalmol       Date:  2006-09-01       Impact factor: 5.258

View more
  38 in total

1.  Use of patient-reported outcomes in medical product development: a report from the 2009 NEI/FDA Clinical Trial Endpoints Symposium.

Authors:  Rohit Varma; Elaine A Richman; Frederick L Ferris; Neil M Bressler
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-12       Impact factor: 4.799

2.  [Diagnostics and stage-oriented therapy of keratoconus: introduction to the Homburg keratoconus center (HKC)].

Authors:  S Goebels; B Seitz; A Langenbucher
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

3.  [The eye, vision and vertigo].

Authors:  P Franko Zeitz; S Hegemann
Journal:  HNO       Date:  2013-09       Impact factor: 1.284

4.  A Large-Scale Computational Analysis of Corneal Structural Response and Ectasia Risk in Myopic Laser Refractive Surgery.

Authors:  William Joseph Dupps; Ibrahim Seven
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

Review 5.  New clinical pathways for keratoconus.

Authors:  D M Gore; A J Shortt; B D Allan
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

6.  Asymmetry in keratoconus and vision-related quality of life.

Authors:  Lisa A Jones-Jordan; Jeffrey J Walline; Loraine T Sinnott; Steven M Kymes; Karla Zadnik
Journal:  Cornea       Date:  2013-03       Impact factor: 2.651

7.  The lifetime economic burden of keratoconus: a decision analysis using a markov model.

Authors:  Ronald L Rebenitsch; Steven M Kymes; Jeffrey J Walline; Mae O Gordon
Journal:  Am J Ophthalmol       Date:  2011-02-18       Impact factor: 5.258

8.  Noninvasive Assessment of Corneal Crosslinking With Phase-Decorrelation Optical Coherence Tomography.

Authors:  Brecken J Blackburn; Shi Gu; Matthew R Ford; Vinícius de Stefano; Michael W Jenkins; William J Dupps; Andrew M Rollins
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

9.  The influence of the refractive correction on the vision-related quality of life in keratoconus patients.

Authors:  Sara Ortiz-Toquero; Sofia Perez; Guadalupe Rodriguez; Victoria de Juan; Agustin Mayo-Iscar; Raul Martin
Journal:  Qual Life Res       Date:  2015-09-03       Impact factor: 4.147

10.  Effects and adverse events after CXL for keratoconus are independent of age: a 1-year follow-up study.

Authors:  P B Baenninger; L M Bachmann; L Wienecke; C Kaufmann; M A Thiel
Journal:  Eye (Lond)       Date:  2014-03-14       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.